Colon Cancer Assay Overview Colon Patient Eligibility Colon Recurrence Risk Limitations Colon Recurrence Score Reports
Physician

Physician "Testimonials"

Find out what other doctors think
about Oncotype DX.

Watch the Video >>

Recurrence Score Values<br />Predict Individual<br />Recurrence Risk

Recurrence Score Values
Predict Individual
Recurrence Risk



Learn More >>

  Pathology Guidelines

  Pathology Guidelines


  Download the guidelines now.


  Download >>

Healthcare Professionals

The Oncotype DX Colon Cancer Assay is clinically validated for recurrence risk in both Stage II and Stage III colon cancer.

The Oncotype DX Colon Cancer Assay is a 12-gene assay that provides an individualized score reflective of the risk of colon cancer recurrence for individual patients with Stage II or Stage III colon cancer. This quantitative information about colon cancer recurrence risk, based on the biology of a patient’s specific tumor, may help to inform individualized adjuvant treatment decisions in patients with Stage II or Stage III colon cancer.